1,329
Views
40
CrossRef citations to date
0
Altmetric
Brief Report

TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b

, , , , , , & show all
Pages 687-693 | Published online: 24 Aug 2012

References

  • Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860 - 7; http://dx.doi.org/10.1038/nature01322; PMID: 12490959
  • Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883 - 99; http://dx.doi.org/10.1016/j.cell.2010.01.025; PMID: 20303878
  • Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005; 65:5009 - 14; http://dx.doi.org/10.1158/0008-5472.CAN-05-0784; PMID: 15958541
  • Huang B, Zhao J, Shen S, Li H, He KL, Shen GX, et al. Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res 2007; 67:4346 - 52; http://dx.doi.org/10.1158/0008-5472.CAN-06-4067; PMID: 17483348
  • Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 2006; 66:3859 - 68; http://dx.doi.org/10.1158/0008-5472.CAN-05-3948; PMID: 16585214
  • Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28:367 - 88; http://dx.doi.org/10.1146/annurev.immunol.021908.132603; PMID: 20192808
  • Huang B, Zhao J, Unkeless JC, Feng ZH, Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 2008; 27:218 - 24; http://dx.doi.org/10.1038/sj.onc.1210904; PMID: 18176603
  • DeNardo DG, Johansson M, Coussens LM. Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 2008; 27:11 - 8; http://dx.doi.org/10.1007/s10555-007-9100-0; PMID: 18066650
  • Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 2009; 86:1065 - 73; http://dx.doi.org/10.1189/jlb.0609385; PMID: 19741157
  • Davidson-Moncada J, Papavasiliou FN, Tam W. MicroRNAs of the immune system: roles in inflammation and cancer. Ann N Y Acad Sci 2010; 1183:183 - 94; http://dx.doi.org/10.1111/j.1749-6632.2009.05121.x; PMID: 20146715
  • Sonkoly E, Pivarcsi A. microRNAs in inflammation. Int Rev Immunol 2009; 28:535 - 61; http://dx.doi.org/10.3109/08830180903208303; PMID: 19954362
  • Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654 - 9; http://dx.doi.org/10.1038/ncb1596; PMID: 17486113
  • Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, et al. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 2010; 5:e11803; http://dx.doi.org/10.1371/journal.pone.0011803; PMID: 20668554
  • Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, Akhmedov NB, et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 2009; 4:e4722; http://dx.doi.org/10.1371/journal.pone.0004722; PMID: 19266099
  • VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59:277 - 87; http://dx.doi.org/10.1016/S0008-6363(03)00367-5; PMID: 12909311
  • Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004; 11:156 - 64; http://dx.doi.org/10.1097/01.moh.0000131441.10020.87; PMID: 15257014
  • Hugel B, Martínez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005; 20:22 - 7; http://dx.doi.org/10.1152/physiol.00029.2004; PMID: 15653836
  • Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20:1487 - 95; http://dx.doi.org/10.1038/sj.leu.2404296; PMID: 16791265
  • Mack M, Kleinschmidt A, Brühl H, Klier C, Nelson PJ, Cihak J, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 2000; 6:769 - 75; http://dx.doi.org/10.1038/77498; PMID: 10888925
  • Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107:1047 - 57; http://dx.doi.org/10.1161/CIRCRESAHA.110.226456; PMID: 21030722
  • Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9:581 - 93; http://dx.doi.org/10.1038/nri2567; PMID: 19498381
  • Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103:2257 - 61; http://dx.doi.org/10.1073/pnas.0510565103; PMID: 16461460
  • Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39:493 - 506; http://dx.doi.org/10.1016/j.molcel.2010.07.023; PMID: 20797623
  • Löffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermüller J, Kretzschmar AK, et al. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 2007; 110:1330 - 3; http://dx.doi.org/10.1182/blood-2007-03-081133; PMID: 17496199
  • Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009; 139:693 - 706; http://dx.doi.org/10.1016/j.cell.2009.10.014; PMID: 19878981
  • Savina A, Furlán M, Vidal M, Colombo MI. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem 2003; 278:20083 - 90; http://dx.doi.org/10.1074/jbc.M301642200; PMID: 12639953
  • Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16:3 - 9; http://dx.doi.org/10.1016/j.smim.2003.10.003; PMID: 14751757
  • Nightingale TD, White IJ, Doyle EL, Turmaine M, Harrison-Lavoie KJ, Webb KF, et al. Actomyosin II contractility expels von Willebrand factor from Weibel-Palade bodies during exocytosis. J Cell Biol 2011; 194:613 - 29; http://dx.doi.org/10.1083/jcb.201011119; PMID: 21844207
  • Masedunskas A, Sramkova M, Parente L, Sales KU, Amornphimoltham P, Bugge TH, et al. Role for the actomyosin complex in regulated exocytosis revealed by intravital microscopy. Proc Natl Acad Sci U S A 2011; 108:13552 - 7; http://dx.doi.org/10.1073/pnas.1016778108; PMID: 21808006
  • le Duc Q, Shi Q, Blonk I, Sonnenberg A, Wang N, Leckband D, et al. Vinculin potentiates E-cadherin mechanosensing and is recruited to actin-anchored sites within adherens junctions in a myosin II-dependent manner. J Cell Biol 2010; 189:1107 - 15; http://dx.doi.org/10.1083/jcb.201001149; PMID: 20584916
  • Schulte LN, Eulalio A, Mollenkopf HJ, Reinhardt R, Vogel J. Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family. EMBO J 2011; 30:1977 - 89; http://dx.doi.org/10.1038/emboj.2011.94; PMID: 21468030
  • Nelson D, Ganss R. Tumor growth or regression: powered by inflammation. J Leukoc Biol 2006; 80:685 - 90; http://dx.doi.org/10.1189/jlb.1105646; PMID: 16864602
  • Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 2006; 72:1605 - 21; http://dx.doi.org/10.1016/j.bcp.2006.06.029; PMID: 16889756
  • Tang K, Liu J, Yang Z, Zhang B, Zhang H, Huang C, et al. Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis. Biochem Biophys Res Commun 2010; 400:432 - 6; http://dx.doi.org/10.1016/j.bbrc.2010.08.095; PMID: 20801099
  • Huang B, Zhao J, Lei Z, Shen S, Li D, Shen GX, et al. miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 2009; 10:180 - 5; http://dx.doi.org/10.1038/embor.2008.224; PMID: 19098714